Cell Culture Market by Product, Application, End-Use

List of Tables

[186 Pages Report] The Cell Culture Market size was estimated at USD 26.29 billion in 2023 and expected to reach USD 30.12 billion in 2024, at a CAGR 14.58% to reach USD 68.20 billion by 2030.

Cell culture is a laboratory method used to grow cells in a controlled environment outside of their natural setting, such as a living organism. This method allows researchers and scientists to study the behavior, biology, and physiology of cells in detail. Cell culture is utilized in various fields, including medical research, pharmaceuticals, biotechnology, and even some aspects of manufacturing. The applications of cell culture technology are vast and varied, encompassing drug development, vaccine production, cancer research, genetic engineering, and the manufacture of biologics, among others. It plays a crucial role in developing new medicines, testing for toxicity, and understanding disease mechanisms. In the pharmaceutical and biotechnology industries, cell culture is pivotal in producing biopharmaceuticals and antibodies. Moreover, its role in regenerative medicine and tissue engineering underlines its significance in developing therapeutic strategies for chronic diseases and conditions. Several factors contribute positively to the growth of the cell culture market, including innovations in cell culture technologies, such as 3D cell culture and automated cell culture systems, growing demand for monoclonal antibodies for therapeutic applications, higher investment in biotechnology and pharmaceutical research activities, and rising incidence of chronic diseases worldwide. However, the cell culture market faces certain limitations, such as the high costs associated with advanced cell culture technologies, ethical issues, the complexity of maintaining cultures, and the risk of contamination. On the other hand, advancements in 3D cell culture technology, the use of cell culture in personalized medicine for tailoring treatments to individual genetic profiles, research into cell culture applications in regenerative medicine, and the burgeoning field of cultured meat, using cell culture for sustainable food production opens new avenues for the development of cell culture market.

KEY MARKET STATISTICS
Base Year [2023]	USD 26.29 billion
Estimated Year [2024]	USD 30.12 billion
Forecast Year [2030]	USD 68.20 billion
CAGR (%)	14.58%

Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features

Consumables are products that are regularly used up and need replacement. They play a critical role in ensuring the quality and integrity of cell culture work. Bioreactor accessories are components used with bioreactors, devices that support a biologically active environment, to improve their efficiency and output. Media is the nutrient-rich solution that cells grow in, and It can be divided into classical media & salts and serum-free media. Reagents are substances or compounds added to the cell culture to bring about a desired effect, such as antibiotics/antimycotics used to prevent bacterial/fungal contamination; attachment & matrix factors to help cells attach to the culture vessel; and balanced salt solutions to maintain the osmotic balance and pH. Cell factory systems/cell stacks, flasks, and multiwell plates are containers where cells are grown. They come in various sizes and shapes, tailored to different types of cell culture needs. Conventional bioreactors and single-use bioreactor devices are essential for growing cells in large quantities for research or production purposes. Single-use bioreactors are particularly noted for their convenience and reduced contamination risk. Cryostorage systems, refrigerators & freezers are vital for preserving cells and biological materials at appropriate temperatures, ensuring they remain viable over time. Autoclaves, biosafety cabinets, and carbon dioxide incubators are essential to maintain a sterile environment, ensuring the safety and integrity of cell cultures. Consumables are a continuous expense and can significantly impact the overall cost of cell culture operations in the long term. In contrast, equipment represents a higher initial investment but offers a longer service life, potentially reducing costs over time. Selection of consumables often focuses on quality, batch consistency, and ethical considerations, whereas equipment preferences lean towards reliability, scalability, and advanced features that enhance culture conditions and monitoring.

End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy

In hospitals and diagnostic laboratories, cell culture is primarily employed for diagnostic purposes, including cancer diagnosis, virology studies, and drug screening. The emphasis is on accuracy, reliability, and speed, with a growing interest in automated cell culture systems to streamline workflow and reduce human error. Pharmaceutical & biotechnology companies prioritize scalability, consistency, and regulatory compliance, given the cell culture applications in drug development, biologics production, and vaccine manufacturing. The focus is on high-yield, cost-effective culture systems that can expedite the time-to-market for new therapeutics. Research and academic institutes focus on flexibility, variety, and specificity in cell culture products to support a broad range of research areas, including stem cell research, cancer research, and regenerative medicine. The demand here is for specialized media formulations, advanced culture systems such as 3D cultures, and support for cutting-edge research endeavors. Upon comparing the three segments, it becomes evident that each has unique requirements shaped by their end goals. Hospitals and diagnostic laboratories prioritize efficiency and diagnostic accuracy, pharmaceutical and biotechnology companies focus on scalability and compliance for therapeutic production, and research and academic institutes demand versatility for a wide swath of research applications.

Regional Insights

The United States, being a hub for biotechnological research and development, stands out as a significant market for cell culture products. The demand here is driven by a robust research infrastructure, substantial investments in life sciences, and the existence of major pharmaceutical and biotechnology companies. The focus on personalized medicine and regenerative therapies further boosts the market. The South American cell culture market is in a growth phase, fueled by increasing investment in research and development by both public and private sectors. The Asia Pacific region is experiencing rapid growth in cell culture demand due to its expanding biopharmaceutical sector, increasing investments in life sciences, and government support for biotechnology startups. China's market is booming, supported by government initiatives aimed at advancing regenerative medicine, biologics production, and stem cell research. Japan's sophisticated healthcare system and strong emphasis on quality are significant markets for advanced cell culture systems. India's cell culture market is growing, fueled by its burgeoning biotech industry, increased biomedical research, and the production of vaccines and biologics. The EU stands out for its strong research capabilities, regulatory frameworks, and substantial investments in the biotechnology and pharmaceutical sectors. The demand for cell culture products is driven by active research areas, including cancer research, regenerative medicine, and vaccine production. Collaborative research initiatives across member states further enhance the market. The Middle East and Africa region, although emerging, shows potential for growth in cell culture due to increasing healthcare investment and a gradual shift towards research and developmental activities in the life sciences sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Bioreactor Accessories
  - Sera, Media, and Reagents
    - Media Classical Media & Salts

Serum-Free Media

Specialty Media

Stem Cell Culture Media

Reagents Antibiotics/Antimycotics

Attachment & Matrix Factors

Balanced Salt Solutions

Buffers & Chemicals

Cell Dissociation Reagents

Contamination Detection Kits

Cryoprotective Reagents

Sera Adult Bovine Sera

Fetal Bovine Sera

Vessels
- Cell Factory Systems/Cell Stacks
- Flasks
- Multiwell Plates
- Petri Dishes
- Roller/Roux Bottles

Equipment
- Bioreactors
  - Conventional Bioreactors
  - Single-Use Bioreactors

Storage Equipment
- Cryostorage System
- Refrigerators & Freezers

Supporting Equipment
- Autoclaves
- Biosafety Cabinets
- Carbon Dioxide Incubators
- Cell Counters
- Centrifuges
- Filtration System
- Microscopes

Application
- Biopharmaceutical Production
  - Monoclonal Antibody Production
  - Vaccine Production

Diagnostics
Drug Screening & Development
Stem Cell Research
Tissue Engineering & Regenerative Medicine

End-Use
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Culture Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Culture Market?

3. What are the technology trends and regulatory frameworks in the Cell Culture Market?

4. What is the market share of the leading vendors in the Cell Culture Market?

5. Which modes and strategic moves are suitable for entering the Cell Culture Market?

Product Code: MRR-034230D3E63B

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
  - 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
  - 5.1.1.3. Rising incidence of chronic diseases worldwide
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
- 5.1.3. Opportunities
  - 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
  - 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
- 5.1.4. Challenges
  - 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
- 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Cell Culture Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Equipment

7. Cell Culture Market, by Application

7.1. Introduction
7.2. Biopharmaceutical Production
7.3. Diagnostics
7.4. Drug Screening & Development
7.5. Stem Cell Research
7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research & Academic Institutes

9. Americas Cell Culture Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cell Culture Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
- 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
- 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio